HOME › DRUGS › SELINEXOR
ACTIVE SUBSTANCE / INN

SELINEXOR

Brand name(s): Nexpovio, XPOVIO
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA212306
Multiple Myeloma
ACTIVE SUBSTANCE
Selinexor
REGULATORS
FDA · EMA
SPONSORS / MAH
KARYOPHARM THERAPS, Stemline Therapeutics B.V.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
XPOVIONDA212306KARYOPHARM THERAPSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NexpovioStemline Therapeutics B.V.Authorised26/03/2021Multiple Myeloma

FULL INTELLIGENCE ON SELINEXOR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →